Search

everythinglearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Lactate production is important for activating hair growth stem cells.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

The research found that the gene activity in mouse skin stem cells changes significantly as they age.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Key genes influencing sheep hair follicle development were identified, aiding wool breeding and understanding human hair conditions.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.